Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Shionogi & Co. has been awarded a $375 million project agreement by the Biomedical Advanced Research and Development ...

Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) ...

January 2025 – LTS LOHMANN Therapie-Systeme AG (“LTS”), a leading Pharmaceutical technology company, is proud to announces ...

ANDERNACH, GERMANY - Newsaktuell - 14 January 2025 - LTS LOHMANN Therapie-Systeme AG (LTS), a leading <a target=_blank href= ...

By signing up with an email address, I acknowledge that I have read ... the study will progress following the Biomedical Advanced Research and Development Authority's (BARDA's) approval to the second ...

PopVax awarded $2M for its patch-delivered mRNA influenza vaccine in collaboration with LTS Lohmann as part of BARDA’s Patch Forward Prize.

Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines that is based on dissolvable microarrays, ...

This option is part of Emergent’s existing 10-year contract with BARDA for advanced development and procurement of Ebanga™, with a maximum value of $704 millionProgram progress and performance ...

We are committed to delivering solutions that address unmet medical needs and improve public health ... a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract ...

SASSA grand beneficiaries at Rosendaal Sec school in Cape Town's Delft, waiting for Minister Tolashe to address them on 9 January 2025. Picture: Ntuthuzelo Nene/Eyewitness News CAPE TOWN - Social ...